AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- May 2024 -
 
A comprehensive review of Prof... 25
The role of nitro oxidative fa... 13
Diagnostic value of stress myo... 13
Effect of Systemic Inflammator... 13
Evaluation of routine laborato... 12
Romanian Review of Laboratory ... 11
Correlations of expressions of... 11
Monitoring the sensitivity of ... 10
Evaluation of cytotoxicity and... 9
Understanding the key differen... 8

Log in

Concept, Design & Programming
Dr. Adrian Man

   
  Articles published by Rodica,Bălaşa
 
  1 The direct deleterious effect of Th17 cells in the nervous system compartment in multiple sclerosis and experimental autoimmune encephalomyelitis: one possible link between neuroinflammation and neurodegeneration
    Authors: Rodica Balasa, Smaranda Maier, Laura Barcutean, Adina Stoian, Anca Motataianu
   
     
  2 Correction of the article: Plasma phosphorylated neurofilament heavy chains as a potential marker for ischemic stroke patients
    Authors: Adina Huțanu, Smaranda Maier, Rodica Bălaşa, Oana Roxana Oprea, Ştefan Barbu, Septimiu Voidăzan, Minodora Dobreanu
   
     
  3 Plasma phosphorylated neurofilament heavy chains as a potential marker for ischemic stroke patients
    Authors: Adina Huțanu, Smaranda Maier, Rodica Bălaşa, Oana Roxana Oprea, Ştefan Barbu, Septimiu Voidăzan, Minodora Dobreanu
   
     
  4 CXCL13 levels are more increased in cerebrospinal fluid and plasma of patients with acute infectious than in non-infectious diseases of the central nervous system
    Authors: Brîndușa Țilea, Septimiu Voidazan, Rodica Balasa, Adina Hutanu, Andrea Fodor
   
     
  5 A case of fatal acute intermittent porphyria: laboratory diagnosis and pathogenesis considerations
    Authors: Rodica Bălaşa, Smaranda Maier, Anca Moţăţăianu, Zoltan Bajko, Otilia Moldovan, Erzsébet Benedek
   
     
  6 Does the serum IL-17 titer influence the efficacy of interferon-β treatment in multiple sclerosis patients?
    Authors: Rodica Bălaşa, Adina Huţanu, Z. Bajko, Camelia Feier, I. Pascu
   
     
  7 Incidence and clinical significance of binding antibodies and their relationships with neutralizing antibodies, both induced by interferon-β treatment in multiple sclerosis patients
    Authors: Rodica Bălaşa, Adina Huţanu, Camelia Feier, Zoltan Bajko, Ion Pascu